PLCB2 and renal cell carcinoma: Further high-throughput RNA sequencing and molecular assays demonstrated that PLCB2 acts as a key mediator connecting the Wnt and PI3K/AKT pathways to regulate the EMT, critically influencing RCC cell proliferation, migration, and invasion.